🇺🇸 FDA
Patent

US 6933274

Methods for treatment of diabetes using a peptide analogues of insulin

expired A61KA61K38/00

Quick answer

US patent 6933274 (Methods for treatment of diabetes using a peptide analogues of insulin) held by Neurocrine Biosciences, Inc. expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Aug 23 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K38/00